Yuta Baba
Showa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Clinical Outcomes of Pola-R-CHP Therapy in Patients Aged >80 Years With Diffuse Large B-Cell Lymphoma.
Journal: Anticancer research
Published: April 17, 2026
Evaluation of the Usefulness of Machine Learning and Artificial Intelligence on Hyperspectral Images in the Diagnosis of Myelodysplastic Syndrome.
Journal: Journal of biophotonics
Published: March 12, 2026
Efficacy of video-otoscope-guided septum bulla fenestration and middle ear lavage for treating otitis media in cats.
Journal: Journal of feline medicine and surgery
Published: October 21, 2025
Intestinal and esophageal microbiota in esophageal cancer development and treatment.
Journal: Gut microbes
Published: May 16, 2025
Acute Myeloid Leukemia with MYC Amplification on a Ring Chromosome 8.
Journal: Internal medicine (Tokyo, Japan)
Published: April 20, 2025
The antitumor mechanism of oclacitinib in canine lymphoma.
Journal: Scientific reports
Published: February 28, 2025
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in mice.
Journal: European journal of pharmacology
Published: December 08, 2024
Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: November 15, 2024
Short-term administration of oclacitinib with concomitant medications in canine epitheliotropic lymphoma: A retrospective study of eight dogs.
Journal: Veterinary dermatology
Published: November 07, 2024
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 21, 2024
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.
Journal: International journal of cancer
Published: September 01, 2024
Last Updated: 09/26/2026